Ovarian Carcinomas: CCN Genes Are Aberrantly Expressed and CCN1 Promotes Proliferation of these Cells
Autor: | Hani Gabra, Dong Xie, Carl W. Miller, William S. Yi, Dong Yin, Miriam L. Popoviciu, Heming Wang, H. Phillip Koeffler, Diane Scott, J. W. Said, Sigal Gery |
---|---|
Rok vydání: | 2005 |
Předmět: |
Adult
Cancer Research endocrine system diseases Angiogenesis medicine.medical_treatment Blotting Western Transplantation Heterologous Mice Nude Apoptosis Biology Transfection Carboplatin Immediate-Early Proteins Mice Cell Line Tumor medicine Animals Humans Protein Isoforms RNA Small Interfering Protein kinase B Aged Cell Proliferation Aged 80 and over Ovarian Neoplasms Reverse Transcriptase Polymerase Chain Reaction Cell growth Growth factor Epithelial Cells Neoplasms Experimental Middle Aged Blotting Northern medicine.disease Immunohistochemistry female genital diseases and pregnancy complications Gene Expression Regulation Neoplastic Oncology Cell culture Cancer research Intercellular Signaling Peptides and Proteins Female Ectopic expression Cisplatin Signal transduction Ovarian cancer Neoplasm Transplantation Cysteine-Rich Protein 61 |
Zdroj: | Clinical Cancer Research. 11:7243-7254 |
ISSN: | 1557-3265 1078-0432 |
DOI: | 10.1158/1078-0432.ccr-05-0231 |
Popis: | Purpose: The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family consists of six matricellular proteins that are involved in various cellular functions, such as proliferation, development, and angiogenesis. The purpose of this study was to explore the possibility that CCN genes are involved in ovarian cancers. Experimental Design: We quantified CCN expression in a series of 59 ovarian cancers using quantitative real-time reverse transcription-PCR. CCN1 protein levels were further determined by immunohistochemistry and Western blot analysis. Overexpression and inhibition of CCN1 expression by small interfering RNA were used to examine its role in ovarian cancer cell proliferation in vitro and in vivo. Results: We found dysregulation of levels of the various CCN mRNAs in ovarian cancers compared with their expression in normal whole ovaries. Expression of CCN1 protein was detected in normal ovarian epithelial cells and ovarian tumors as well as in ovarian cancer cell lines. Furthermore, estrogen increased CCN1 mRNA and protein levels in ovarian cancer cells. Ectopic expression of CCN1 enhanced the growth of ovarian cancer cells in liquid culture, whereas inhibition of its expression decreased proliferation and increased apoptosis in these cells. The observed changes in cell growth were accompanied with activation of Akt and extracellular signal-regulated kinase (ERK) signaling pathways. Stable expression of CCN1 in SKOV3 cells significantly increased tumorigenicity in nude mice. Finally, overexpression of CCN1 conferred resistant to carboplatin-induced apoptosis in SKOV3 cells. Conclusions: This is the first study to show abnormalities in CCN expression in ovarian carcinomas. Furthermore, our results suggest that CCN1 may play a role in ovarian carcinogenesis by stimulating survival and antiapoptotic signaling pathways. |
Databáze: | OpenAIRE |
Externí odkaz: |